sharl92

Novacyt is undervalued

sharl92 已更新   
EURONEXT:ALNOV   NOVACYT
Target : €0.85
评论:
News are good, we need volume !
  • NOVACYT 1.12% launches the first of a series of new products in infectious diseases
  • NOVACYT 1.12% Receives €4 Million Loan Facility for Mergers & Acquisitions
  • NOVACYT 1.12% growth reached 35% in 2017
评论:
The target has been reassessed at $90.

免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。